NKGen Biotech, Inc.: Nasdaq/NYSE listing notice — NKGen Biotech receives Nasdaq non-compliance notice for board independence

NKGen Biotech, Inc.

Nasdaq notice dated Feb 13, 2024 due to insufficient independent directors after Alana McNulty's resignation.
Board has 4 directors, only 2 independent; Audit Committee has only 2 independent members (needs 3).
Cure period: until earlier of next annual meeting or Feb 4, 2025 (or Aug 2, 2024 if meeting before Aug 2).
Company plans to elect one or more independent directors during cure period.
No immediate effect on listing or trading of NKGN common or NKGNW warrants.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

NKGen Biotech, Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(b)(1)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: board independence
Rules: 5605, 5605(b)(1)(A)

Exact text from the filing

February 13, 2024, NKGen Biotech, Inc. (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated February 13, 2024, indicating that, as a result of Alana McNulty’s resignation from the Board of Directors of the Company (the “Board”) and audit committee of the Board (the “Audit Committee”), effective February 4, 2024, that the Company is not currently in compliance with Nasdaq Listing Rule 5605, which requires that (i) a majority of the Board be comprised of independent directors and (ii) the Audit Committee is comprised of at least three indepen

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-025024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.